FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
This roundup highlights recent FDA updates related to drug approvals and devices used by optometric eye care professionals.
Reduced optic nerve head blood flow seems to be correlated with impaired pupil response in patients with glaucoma.
The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Abstract: Electro-optical modulators are key components in photonic communications, and they are decisively important for the quality and data transmission rates. They encode information by modulating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback